Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Ipca Laboratories Ltd. Call Transcript 2022

Feb 10, 2022

61700_rns_2022-02-10_84cb1bb5-cfe0-4129-a0e2-60fde1fe46db.pdf

Call Transcript

Open in viewer

Opens in your device viewer

THRU ONLINE FILING

February 10, 2022

BSE Ltd. Phiroze Jeejeebhoy Towers Dalai Street Mumbai 400 023 Scrip Code - 524494

National Stock Exchange India Limited, Exchange Plaza, C-1, Block-G, Bandra Kurla Complex, Bandra - (East). Mumbai-400051. Scrip Code : IPCALAB

Dear Sirs,

Further to our letter dated 9th February, 2022, please note that due to unavaoidable circumstances, the timing of the conference call to discuss the Company's Q3FY22 earnings and business update has been revised.

Accordingly, Conference Call to discuss the Company's Q3FY22 earnings and business update will now be held at 16.30 hrs 1ST on Tuesday, 15th February, 2022.

Please find enclosed herewith the revised conference call invite/details.

This is for your information / record.

Thanking you

Yours faithfully For Ipca Laboratories Limited

Harish P. Kamath Corporate Counsel & Company Secretary

Enel: a/a

Ipca Laboratories Ltd. www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837

INVITE FOR Q3FY22 EARNINGS CALL OF IPCA LABORATORIES LTD

TUESDAY. 15th FEBRUARY, 2022 AT 16.30 HRS 1ST

Mumbai, 10th February, 2022: Ipca Laboratories Limited (BSE: 524494, NSE:IPCALAB) will organize a conference call for investors and analysts on Tuesday, 15th February, 2022 from 16.30 hrs to 16.30 hrs 1ST to discuss Q3FY22 earnings and business update. The conference call follows the announcement of the Company's Q3FY22 financial results on Monday, 14th February, 2022.

Ipca Laboratories Limited management will be represented by Mr. A K Jain - Joint Managing Director and Mr. Harish Kamath - Corporate Counsel & Company Secretary. .

The call will be hosted by Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.).

Details of the conference call are as under:

Dial-in numbers

Universal Access: +91 22 6280 1384 + 91 22 7115 8285

Diamond Passcode link : click here

https://services.choruscall.in/DiamondPassRegistration/reqister7confirmationNumber =5613626&linkSecurityString=17468642a0

International Dial-In

Hong
Kong
Singapore UK USA
19.00 (HKT) 19.00 (SGT) 12.00 (BST) 06.00
(EDT)'
Toll +852 30186877 +65 31575746 +44 2034785524 +1 3233868721

Please dial-in at least 5-10 minutes prior to the conference schedule to ensure that you are connected to the call in time.

For further information please contact

Anusha Kawthankar Ipca Laboratories Limited

Tel:+91-22-6210 6051 [email protected]

Nitin Agarwal / Parth Dalia Dam Capital Advisors Ltd. (Formerly IDFC Securities Ltd.) Tel: +91- 9820413251 / 9867224187 [email protected] / [email protected]

. _ Ipca Laboratories Ltd.

www.ipca.com

125, Kandivli Industrial Estate, CIS No. 328, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T:+91 22 6210 5000 F:+91 22 6210 5005 Regd. Office: 48, Kandivli Industrial Estate, Kandivli (West), Mumbai 400 067 (Maharashtra), India | T: +91 22 6647 4444 E: [email protected] CIN: L24239MH1949PLC007837